Literature DB >> 2566580

In vivo expression and variation of Escherichia coli type 1 and P pili in the urine of adults with acute urinary tract infections.

P V Kisielius1, W R Schwan, S K Amundsen, J L Duncan, A J Schaeffer.   

Abstract

In vivo expression of pili by Escherichia coli in the urine of 41 adults with lower urinary tract infections was analyzed by immunostaining with polyclonal antiserum to type 1 and P pili. Type 1 pili were detected in 31 of 41 urine specimens, while P pili were detected in 6 of 18 specimens. The piliation status of bacterial populations in urine was heterogeneous, varying from predominantly piliated to a mixture of piliated and nonpiliated cells. Bacteria frequently adhered to exfoliated uroepithelial cells and leukocytes in urine. Expression of pili in vivo did not always correlate with the hemagglutination phenotype after growth in vitro. Strains isolated from different sites in the urogenital tract of two individuals showed phenotypic variation in the state of piliation. The results demonstrate that E. coli type 1 and P pili are expressed and are subject to variation in vivo during acute urinary tract infections in adults.

Entities:  

Mesh:

Year:  1989        PMID: 2566580      PMCID: PMC313335          DOI: 10.1128/iai.57.6.1656-1662.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Improved transmission electron microscopy technique for the study of cytologic material.

Authors:  S Hultgren; D F Hidvegi
Journal:  Acta Cytol       Date:  1985 Mar-Apr       Impact factor: 2.319

2.  Frequency of gene sequences necessary for pyelonephritis-associated pili expression among isolates of Enterobacteriaceae from human extraintestinal infections.

Authors:  R A Hull; S I Hull; S Falkow
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

3.  Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control.

Authors:  B I Eisenstein
Journal:  Science       Date:  1981-10-16       Impact factor: 47.728

4.  Chi-dependent DNA strand cleavage by RecBC enzyme.

Authors:  A S Ponticelli; D W Schultz; A F Taylor; G R Smith
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

5.  Gal-Gal binding and hemolysin phenotypes and genotypes associated with uropathogenic Escherichia coli.

Authors:  P O'Hanley; D Low; I Romero; D Lark; K Vosti; S Falkow; G Schoolnik
Journal:  N Engl J Med       Date:  1985-08-15       Impact factor: 91.245

6.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.

Authors:  S J Hultgren; T N Porter; A J Schaeffer; J L Duncan
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

7.  Occurrence of type-1C fimbriae on Escherichia coli strains isolated from human extraintestinal infections.

Authors:  A Pere; M Leinonen; V Väisänen-Rhen; M Rhen; T K Korhonen
Journal:  J Gen Microbiol       Date:  1985-07

8.  Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis.

Authors:  P O'Hanley; D Lark; S Falkow; G Schoolnik
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

9.  Frequency among Enterobacteriaceae of the DNA sequences encoding type 1 pili.

Authors:  K Buchanan; S Falkow; R A Hull; S I Hull
Journal:  J Bacteriol       Date:  1985-05       Impact factor: 3.490

10.  Environmental temperature regulates transcription of a virulence pili operon in E. coli.

Authors:  M Göransson; B E Uhlin
Journal:  EMBO J       Date:  1984-12-01       Impact factor: 11.598

View more
  25 in total

1.  Cpx signaling pathway monitors biogenesis and affects assembly and expression of P pili.

Authors:  D L Hung; T L Raivio; C H Jones; T J Silhavy; S J Hultgren
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

3.  Role of sigma E-regulated genes in Escherichia coli uropathogenesis.

Authors:  Peter Redford; Rodney A Welch
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Conformational inactivation induces immunogenicity of the receptor-binding pocket of a bacterial adhesin.

Authors:  Dagmara I Kisiela; Victoria B Rodriguez; Veronika Tchesnokova; Hovhannes Avagyan; Pavel Aprikian; Yan Liu; Xue-Ru Wu; Wendy E Thomas; Evgeni V Sokurenko
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

5.  Role for FimH in Extraintestinal Pathogenic Escherichia coli Invasion and Translocation through the Intestinal Epithelium.

Authors:  Nina M Poole; Sabrina I Green; Anubama Rajan; Luz E Vela; Xi-Lei Zeng; Mary K Estes; Anthony W Maresso
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

6.  Potential role of phase variation of type 1 pili in urinary tract infection. and bacterial prostatitis.

Authors:  A J Schaeffer
Journal:  Infection       Date:  1991       Impact factor: 3.553

7.  Roles of glycoproteins and oligosaccharides found in human vaginal fluid in bacterial adherence.

Authors:  N Rajan; Q Cao; B E Anderson; D L Pruden; J Sensibar; J L Duncan; A J Schaeffer
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

8.  In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection.

Authors:  N W Gunther; V Lockatell; D E Johnson; H L Mobley
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

9.  Down-regulation of the kps region 1 capsular assembly operon following attachment of Escherichia coli type 1 fimbriae to D-mannose receptors.

Authors:  William R Schwan; Michael T Beck; Scott J Hultgren; Jerry Pinkner; Nathan L Woolever; Thomas Larson
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 10.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.